Literature DB >> 12007600

The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.

Ziyong Sun1, Yu-hong Chen, Ping Wang, Jing Zhang, Victor Gurewich, Peixiang Zhang, Jian-Ning Liu.   

Abstract

Prourokinase-induced plasminogen activation is complex and involves three distinct reactions: (1) plasminogen activation by the intrinsic activity of prourokinase; (2) prourokinase activation by plasmin; (3) plasminogen activation by urokinase. To further understand some of the mechanisms involved, the effects of epsilon-aminocaproic acid (EACA), a lysine analogue, on these reactions were studied. At a low range of concentrations (10-50 microM), EACA significantly inhibited prourokinase-induced (Glu-/Lys-) plasminogen activation, prourokinase activation by Lys-plasmin, and (Glu-/Lys-) plasminogen activation by urokinase. However, no inhibition of plasminogen activation by Ala158-prourokinase (a plasmin-resistant mutant) occurred. Therefore, the overall inhibition of EACA on prourokinase-induced plasminogen activation was mainly due to inhibition of reactions 2 and 3, by blocking the high-affinity lysine binding interaction between plasmin and prourokinase, as well as between plasminogen and urokinase. These findings were consistent with kinetic studies which suggested that binding of kringle 1-4 of plasmin to the N-terminal region of prourokinase significantly promotes prourokinase activation, and that binding of kringle 1-4 of plasminogen to the C-terminal lysine158 of urokinase significantly promotes plasminogen activation. In conclusion, EACA was found to inhibit, rather than promote, prourokinase-induced plasminogen activation due to its blocking of the high-affinity lysine binding sites on plasmin(ogen).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007600     DOI: 10.1016/s0167-4838(02)00233-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  Fibrin degradation enhances vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro.

Authors:  Katherine A Ahmann; Justin S Weinbaum; Sandra L Johnson; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

2.  Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.

Authors:  Rubí Viedma-Rodríguez; María Guadalupe Martínez-Hernández; Luis Antonio Flores-López; Luis Arturo Baiza-Gutman
Journal:  Mol Cell Biochem       Date:  2017-06-13       Impact factor: 3.396

3.  Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.

Authors:  Paolo Feltracco; Marialuisa Brezzi; Stefania Barbieri; Helmut Galligioni; Moira Milevoj; Cristiana Carollo; Carlo Ori
Journal:  World J Hepatol       Date:  2013-01-27

4.  Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

Authors:  Wendy M Mars; Minji Jo; Steven L Gonias
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  Effect of a nutrient mixture on the localization of extracellular matrix proteins in HeLa human cervical cancer xenografts in female nude mice.

Authors:  M Waheed Roomi; John Cha; Tatiana Kalinovsky; Nusrath Roomi; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Exp Ther Med       Date:  2015-06-23       Impact factor: 2.447

6.  Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture.

Authors:  M W Roomi; N W Roomi; T Kalinovsky; V Ivanov; M Rath; A Niedzwiecki
Journal:  Med Oncol       Date:  2008-01-18       Impact factor: 3.064

Review 7.  Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.

Authors:  A Niedzwiecki; M W Roomi; T Kalinovsky; M Rath
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

8.  A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture.

Authors:  Nobuaki Okumura; Tomohiko Koh; Yuichi Hasebe; Taiichiro Seki; Toyohiko Ariga
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

9.  Suppression of metastasis of intratesticular inoculation of B16FO melanoma cells by a novel nutrient mixture in male athymic nude mice.

Authors:  M Waheed Roomi; Tatiana Kalinovsky; Nusrath W Roomi; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Exp Ther Med       Date:  2012-08-31       Impact factor: 2.447

10.  In vitro and in vivo inhibition of human Fanconi anemia-associated head and neck squamous cell carcinoma by a novel nutrient mixture.

Authors:  M W Roomi; T Kalinovsky; N W Roomi; A Niedzwiecki; M Rath
Journal:  Int J Oncol       Date:  2012-09-24       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.